Understanding and preventing the development of post-stroke dementia

被引:22
作者
Ihara, Masafumi [1 ]
Kalaria, Raj N. [2 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Suita, Osaka 5658565, Japan
[2] Newcastle Univ, Inst Ageing & Hlth Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
基金
英国医学研究理事会;
关键词
Alzheimer's disease; cognitive impairment; dementia; microinfarct; neuroimaging; post-stroke dementia; stroke; vascular dementia; white matter; VASCULAR COGNITIVE IMPAIRMENT; WHITE-MATTER HYPERINTENSITIES; TRANSIENT ISCHEMIC ATTACK; PLACEBO-CONTROLLED TRIAL; MEDIAL TEMPORAL ATROPHY; STROKE PATIENTS; DOUBLE-BLIND; CEREBROVASCULAR-DISEASE; CORTICAL MICROINFARCTS; EXECUTIVE DYSFUNCTION;
D O I
10.1586/14737175.2014.947276
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Post-stroke dementia (PSD) is a clinical entity but it now appears that most of PSD may be categorized as vascular dementia. The well-established relationship between vascular factors and dementia provides a rationale for the implementation of intervention and prevention efforts. Larger primary prevention trials related to lifestyle factors are warranted in association with dementia. Published clinical trials have not been promising and there is meager information on whether PSD can be prevented through the use of pharmacological agents. Control of vascular disease risk and prevention of recurrent strokes are obviously key to reducing the burden of cognitive decline and dementia after stroke. However, modern imaging and analysis techniques will help to elucidate the mechanism of PSD and establish better treatment.
引用
收藏
页码:1067 / 1077
页数:11
相关论文
共 128 条
[1]   Citicoline in stroke and TBI clinical trials [J].
Rao Muralikrishna Adibhatla .
Nature Reviews Neurology, 2013, 9 (3) :173-173
[2]   Topographical and cytopathological lesion analysis of the white matter in Binswanger's disease brains [J].
Akiguchi, I ;
Tomimoto, H ;
Wakita, H ;
Kawamoto, Y ;
Matsuo, A ;
Ohnishi, K ;
Watanabe, T ;
Budka, H .
ACTA NEUROPATHOLOGICA, 2004, 107 (06) :563-570
[3]   Long-term incidence of depression and predictors of depressive symptoms in older stroke survivors [J].
Allan, Louise M. ;
Rowan, Elise N. ;
Thomas, Alan J. ;
Polvikoski, Tuomo M. ;
O'Brien, John T. ;
Kalaria, Raj N. .
BRITISH JOURNAL OF PSYCHIATRY, 2013, 203 (06) :453-460
[4]   Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors [J].
Allan, Louise M. ;
Rowan, Elise N. ;
Firbank, Michael J. ;
Thomas, Alan J. ;
Parry, Stephen W. ;
Polvikoski, Tuomo M. ;
O'Brien, John T. ;
Kalaria, Raj N. .
BRAIN, 2011, 134 :3713-3724
[5]   Delayed poststroke dementia - A 4-year follow-up study [J].
Altieri, M ;
Di Piero, V ;
Pasquini, M ;
Gasparini, M ;
Vanacore, N ;
Vicenzini, E ;
Lenzi, GL .
NEUROLOGY, 2004, 62 (12) :2193-2197
[6]   Long-Term Treatment with Citicoline May Improve Poststroke Vascular Cognitive Impairment [J].
Alvarez-Sabin, Jose ;
Ortega, Gemma ;
Jacas, Carlos ;
Santamarina, Estevo ;
Maisterra, Olga ;
Ribo, Marc ;
Molina, Carlos ;
Quintana, Manuel ;
Roman, Gustavo C. .
CEREBROVASCULAR DISEASES, 2013, 35 (02) :146-154
[7]  
Areosa Sastre A, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD14003154.PUB14651852
[8]   Apolipoprotein E, angiotensin-converting enzyme and α-1-antichymotrypsin genotypes are not associated with post-stroke dementia [J].
Arpa, A ;
del Ser, T ;
Goda, G ;
Barba, R ;
Bornstein, B .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 210 (1-2) :77-82
[9]   Prospective follow-up study between 3 and 15 months after stroke -: Improvements and decline in cognitive function among dementia-free stroke survivors > 75 years of age [J].
Ballard, C ;
Rowan, E ;
Stephens, S ;
Kalaria, R ;
Kenny, RA .
STROKE, 2003, 34 (10) :2440-2444
[10]  
Ballard CG, 2004, NEUROLOGY, V63, P1399